Request Your Free White Paper Now:

"Optimizing Healthcare Resource Utilization: Why Exome or Genome Sequencing Should Be First-Line Diagnostic Tools"

Download this free whitepaper to learn more

Exome and genome sequencing (ES/GS) offer faster, more accurate diagnoses while reducing unnecessary utilization. Yet payor coverage continues to lag despite compelling evidence of clinical and economic benefit.

Download this free white paper to explore:

• How ES/GS improve diagnostic yield across populations with rare disease, neurodevelopmental disorders and in the NICU
• Real-world cost-savings: shorter lengths of stay, fewer low-yield diagnostics, and increased efficiencies
• How fragmented payor policies reduce access, and how alignment with professional guidelines can create better outcomes for patients, providers and payors

Offered Free by: GeneDx
See All Resources from: GeneDx